Clinical Pharmacology & Biopharmaceutics
Open Access

Customizing Yeast Cell Factories: Pioneering Biopharmaceutical Production

Received Date: Apr 01, 2024 / Accepted Date: Apr 30, 2024 / Published Date: Apr 30, 2024

Warning: Undefined variable $i in /efsdata/omicsonline.org/httpdocs/peer-reviewed/abstract-page.php on line 156

Warning: Undefined variable $for_cr in /efsdata/omicsonline.org/httpdocs/peer-reviewed/abstract-page.php on line 156
Copyright: © 0  . This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

To read the full article Peer-reviewed Article PDF

Yeast cell factories have emerged as versatile and robust platforms for the production of biopharmaceuticals, offering a scalable and customizable environment for therapeutic molecule synthesis. This abstract explores the transformative potential of customizing yeast cell factories in biopharmaceutical production, focusing on genetic engineering, pathway optimization, and therapeutic applications. By harnessing the genetic toolkit and metabolic capabilities of yeast, researchers can engineer high-yielding strains capable of producing a diverse array of therapeutic molecules, including proteins, peptides, antibodies, and vaccines. Moreover, yeast-based expression systems offer advantages such as post-translational modifications and scalability, making them attractive platforms for both research and industrial applications.

Keywords